Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$38.60 +3.49 (+9.94%)
At close: Aug 19, 2026 · 4:00 PM UTC

Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026)

Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Haleon 86.50 Bn 85.53 Bn - 8.92 Bn
2 Teva Pharmaceutical Industries 42.71 Bn 39.05 Bn 2.15 Bn 1.17 Bn
3 Zoetis 30.86 Bn 29.18 Bn 1.80 Bn 417.70 Mn
4 Takeda Pharmaceutical 28.50 Bn 22.70 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.06 Bn 19.40 Bn 683.80 Mn 45.80 Mn
6 Viatris 18.84 Bn 17.95 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn 104.20 Mn
8 Vireo Growth 11.86 Bn 11.71 Bn 59.30 Mn 1.08 Bn
9 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 505.90 Mn
10 Amylyx Pharmaceuticals 3.91 Bn 3.91 Bn - 111.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 111.20 Mn
Mar 31, 2026 110.56 Mn
Dec 31, 2025 94.57 Mn
Sep 30, 2025 93.33 Mn
Jun 30, 2025 89.14 Mn
Mar 31, 2025 85.70 Mn
Dec 31, 2024 68.14 Mn
Sep 30, 2024 68.09 Mn
Jun 30, 2024 68.02 Mn
Mar 31, 2024 67.85 Mn
Dec 31, 2023 69.99 Mn
Sep 30, 2023 69.75 Mn
Jun 30, 2023 70.13 Mn
Mar 31, 2023 70.86 Mn
Dec 31, 2022 58.50 Mn
Sep 30, 2022 58.53 Mn
Jun 30, 2022 58.28 Mn
Mar 31, 2022 51.60 Mn
Dec 31, 2021 6.59 Mn
Sep 30, 2021 6.76 Mn